Your browser doesn't support javascript.
loading
Activation of Wnt signaling promotes olaparib resistant ovarian cancer.
Yamamoto, Tomomi M; McMellen, Alexandra; Watson, Zachary L; Aguilera, Jennifer; Ferguson, Rebecca; Nurmemmedov, Elmar; Thakar, Tanay; Moldovan, George-Lucian; Kim, Hyunmin; Cittelly, Diana M; Joglar, Annette M; Brennecke, Elyse P; Wilson, Heidi; Behbakht, Kian; Sikora, Matthew J; Bitler, Benjamin G.
Afiliación
  • Yamamoto TM; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • McMellen A; Cancer Biology Graduate Program, The University of Colorado, Aurora, Colorado.
  • Watson ZL; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Aguilera J; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Ferguson R; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Nurmemmedov E; John Wayne Cancer Center, Los Angeles, California.
  • Thakar T; Department of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
  • Moldovan GL; Department of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
  • Kim H; Division of Medical Oncology, Department of Medicine, Translational Bioinformatics and Cancer Systems Biology Laboratory, Anschutz Medical Campus, University of Colorado, Aurora, Colorado.
  • Cittelly DM; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Joglar AM; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Brennecke EP; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Wilson H; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Behbakht K; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Sikora MJ; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Bitler BG; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Mol Carcinog ; 58(10): 1770-1782, 2019 10.
Article en En | MEDLINE | ID: mdl-31219654
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Ftalazinas / Piperazinas / Poli(ADP-Ribosa) Polimerasas / Inhibidores de Poli(ADP-Ribosa) Polimerasas Límite: Animals / Female / Humans Idioma: En Revista: Mol Carcinog Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Ftalazinas / Piperazinas / Poli(ADP-Ribosa) Polimerasas / Inhibidores de Poli(ADP-Ribosa) Polimerasas Límite: Animals / Female / Humans Idioma: En Revista: Mol Carcinog Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos